Q1 2019 13F Holders as of 31 Mar 2019
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
20,981,027
-
Share change
-
-2,682,822
-
Total reported value
-
$28,114,608
-
Price per share
-
$1.34
-
Number of holders
-
75
-
Value change
-
-$3,339,341
-
Number of buys
-
23
-
Number of sells
-
44
Institutional Holders of TETRAPHASE PHARMACEUTICALS I - COM (TTPH) as of Q1 2019
As of 31 Mar 2019,
TETRAPHASE PHARMACEUTICALS I - COM (TTPH) was held by
75 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
20,981,027 shares.
The largest 10 holders included
BlackRock Inc., VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, DIMENSIONAL FUND ADVISORS LP, STATE STREET CORP, Tekla Capital Management LLC, 683 Capital Management, LLC, TWO SIGMA INVESTMENTS, LP, NORTHERN TRUST CORP, and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
75
institutional shareholders reporting positions in this security
for the Q1 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.